Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

MACK holding history

Merrimack Pharmaceuticals Inc in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MACK overviewAll 13F holders of MACKFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2022
Holdings of MACK by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−73,600−100.0%Sold outHolders
Q4 202273,600$843.5K<0.1%+73,600NewHolders